|
|
| |
|
|
| Division of Medicinal Treatment |
Course of Pharmaceutical Sciences
Department of Clinical Pharmacy |
 |
|
- Establishment of DNA-based diagnosis for tailor-made medicine
- Identification of genes for susceptibility to diseases, responsibility and adverse effects of drugs, and prognosis of diseases
- Elucidation of molecular mechanisms of resistance to anticancer drugs
- Elucidation of molecular mechanisms of carcinogenesis
- Elucidation of molecular mechanisms of etiology and pathophysiology of cleft lip and cleft palate
|
- Ohishi Y et al. Single-nucleotide polymorphism analysis of the multidrug resistance protein 3 gene for the detection of clinical progression in Japanese patients with primary biliary cirrhosis. Hepatology 48:853-862, 2008.
- Kihara R et al. Potency of SMP-601, a novel carbapenem, in hematogenous murine bronchopneumonia caused by methicillin-resistant and vancomycin-intermediate Staphylococcus aureus. Antimicrob Agents Chemother 52:2163-2168, 2008.
- Nakano H et al. Heterogeity of epidermal growth factor receptor mutations within a mixed adenocarcinoma lung node. Lung cancer 60:136-140, 2008.
- Nakano H et al. Methylation status of breast cancer resistance protein detected by methylation-specific PCR is inversely correlated with its expression in drug-resistant lung cancer cells. Cancer 112:1122-1130, 2008.
- Chuan CC et al. Haplotypes of PADI4 susceptible to rheumatoid arthritis are also associated with ulcerative colitis in the Japanese population. Clin Immunol 126:165-171, 2008.
|
|
|
| |
|
|
Cell
Regulation
Contact
